1 completed, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow Mirabegron 25mg: new trials by email Literature Review of Mirabegron 25mg trials Research Report on Mirabegron 25mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
| Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan Mirabegron 25mg - Urinary Incontinence, Overactive Bladder Syndrome | Phase 3 | Completed | Buddhist Tzu Chi General Hospital | 168 | 2015-04-28 | 2017-02-23 |
Urinary Bladder, Overactive (2) · Nocturia (1) · Urinary Incontinence (1)
Buddhist Tzu Chi General Hospital (1) · Far Eastern Memorial Hospital (1)
Taiwan (1)